Zobrazeno 1 - 7
of 7
pro vyhledávání: '"NN Sharkunov"'
Autor:
A E Misyurina, E S Nesterova, NN Sharkunov, S K Kravchenko, V. A. Misyurin, N. A. Lyzhko, DS Mar’in, A. V. Misyurin, M. A. Baryshnikova, NN Kasatkina, YuP Finashutina
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 2, Pp 173-178 (2019)
Aim. To set survival parameters for follicular lymphoma (FL) patients with different PRAME expression levels in tumor cells. Materials & Methods. The study was conducted on samples of lymph nodes, blood, and bone marrow of 34 patients with newly diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d97c7899823ddac4a5e790e94b7608f
https://doaj.org/article/fe7b78cc9eb246668004692ea9745f03
https://doaj.org/article/fe7b78cc9eb246668004692ea9745f03
Autor:
NN Sharkunov, SV Voloshin, MM Pankrashkina, Transfusiology, ya Sovetskaya str., Saint Petersburg, Russian Federation, Immunology, Samory Mashela str., Moscow, Russian Federation, SN Tsareva, EV Motyko, Irina Martynkevich, Fominykh, DI Shikhbabaeva, Irina Zotova, NV Novitskaya, M V Chernikov, VA Shuvaev, VYu Udal’eva, OYu Vinogradova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 4, Pp 288-294 (2018)
Aim. To evaluate the clinical experience of bosutinib use for treatment of chronic myeloid leukemia (CML) patients with intolerance and resistance to other tyrosine kinase inhibitors (TKI), as well as to compare the obtained results with the data of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60db666a29e8a657dd3c09c125d38fb
http://bloodjournal.ru/wp-content/uploads/2018/09/2-1.pdf
http://bloodjournal.ru/wp-content/uploads/2018/09/2-1.pdf
Autor:
AV Chechetkin, E.V. Efremova, SV Voloshin, VA Shuvaev, Fominykh, MM Pankrashkina, Irina Martynkevich, LB Polushkina, KYu Krutikova, NN Sharkunov, OYu Vinogradova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 471-478 (2017)
Background. Myelofibrosis (primary myelofibrosis, postessential trombocythemia myelofibrosis, post-polycythemia myelofibrosis) is the most complex and pressing problem among all Ph-negative myeloproliferative diseases. The present article summarizes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74cd472b8350fcaf98af9c56cdd8dbe9
http://bloodjournal.ru/wp-content/uploads/2017/10/6_1.pdf
http://bloodjournal.ru/wp-content/uploads/2017/10/6_1.pdf
Autor:
E A Nikitin, N.A. Lobanova, D.I. Shihbabaeva, O.Ju. Vinogradova, M.V. Davydovskaja, Vadim V. Ptushkin, V.G. Markarjan, NN Sharkunov, K.A. Kokushkin
Publikováno v:
Pharmacoeconomics: theory and practice. 6:66-66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8548b4bf3fc1f489e92a8e117cde8476
https://doi.org/10.30809/phe.1.2018.31
https://doi.org/10.30809/phe.1.2018.31
Autor:
Moiseeva TN, Al-Radi LS, Sharkunov NN, Chernova NG, Klyasova GA, Gracheva AN, Baryakh EA, Maryin DS, Shitareva IV, Julakyan UL, Kostina IE, Sinitsina MN, Galstyan GM, Kravchenko SK
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2014; Vol. 86 (11), pp. 60-5.
Autor:
Al-Radi LS, Moiseeva TN, Chernova NG, Sharkunov NN, Margolin OV, Shitareva IV, Baryakh EA, Klyasova GA, Roshchina LS, Kostina IE, Kravchenko SK, Pivnik AV, Vorobiov AI
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2014; Vol. 86 (11), pp. 42-9.
[Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia].
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2012; Vol. 84 (11), pp. 71-4.